Human CYP2C19,Low-Reductase
Product Specifications
UNSPSC Description
Human CYP2C19, Low-Reductase, a recombinant CYP2C19, is a member of the CYP enzyme family. CYP2C19 catalyzes metabolism of xenobiotics, including some proton pump inhibitors and antiepileptic drugs[1].
Target Antigen
Cytochrome P450
Type
Enzyme
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/human-cyp2c19-low-reductase.html
Smiles
[HumanCYP2C19,Low-Reductase]
References & Citations
[1]Vignaux PA, et al. Human CYP2C19 Substrate and Inhibitor Characterization of Organophosphate Pesticides. Chem Res Toxicol. 2023 Sep 18;36(9):1451-1455.
Shipping Conditions
Room temperature
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6444718-01 0.1 mL
LPAR5 (Lysophosphatidic Acid Receptor 5, LPA Receptor 5, LPA-5, G-protein Coupled Receptor 92, G-protein Coupled Receptor 93, GPR92, GPR93) (MaxLight 650)
Sign In for Pricing
View Details MBS6444718-02 5x 0.1 mL
LPAR5 (Lysophosphatidic Acid Receptor 5, LPA Receptor 5, LPA-5, G-protein Coupled Receptor 92, G-protein Coupled Receptor 93, GPR92, GPR93) (MaxLight 650)
Sign In for Pricing
View Details